Investors
Key press releases
Key upcoming events
Key corporate presentation
Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on the Euronext Growth Paris (ticker: ALCLS).
Cellectis ADS (Nasdaq)
Ticker: CLLS
$15.0500
-0.1600 (-1.0519%)
- Prev. close
- 15.2100
- Volume
- 57,078
- High
- 15.2400
- Capitalization
- 638.807M
Cellectis (Euronext Growth Paris)
Ticker: ALCLS
€13.1600
+0.1000 (0.7657%)
- Prev. close
- 13.0600
- Volume
- 62,207
- High
- 13.4700
- Capitalization
- 558.585M
Covering research analysts
Barclays - Gena Wang
Bryan Garnier – Marion Levi
Citi - Robyn Karnauskas
Goldman Sachs - Salveen Richter
Jefferies – Biren Amin
Jones Trading - Soumit Roy
Ladenburg – Wangzhi Li
Nomura / Instinet – Christopher Marai
Oddo BHF - Martial Descoutures
Oppenheimer – Hartaj Singh
Portzamparc – Christophe Dombu
Suntrust Robinson – Peter Lawson
Wells Fargo – Jim Birchenough
William Blair – Raju Prasad
Cellectis contact information
Simon Harnest
Investor Relations USA
+1 646 385 9008
Victor Chaulot-Talmon
Investor Relations Europe
+33 (0)1 81 69 17 22
Citibank ADR contact information
Intermediaries & Investors
US: +1 212 723 5435
UK: +44 207 500 2030
Société Générale Securities Services - Ordinary Shares contact information
Call center in English and French
Monday to Friday from 8:30am to 6pm CEST
+33 (0)2 51 85 67 89